Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

The results of a planned interim analysis conducted at week 72 involving the first ... of steatohepatitis was reported in 36.8% of the patients in the semaglutide group and in 22.4% of those ...